1. Ivarsdottir, Erna V, Gudmundsson, Julius, Tragante, Vinicius, Gudbjartsson, Daniel F, Stefansson, Kari. 2024. Gene-based burden tests of rare germline variants identify six cancer susceptibility genes. In Nature genetics, 56, 2422-2433. doi:10.1038/s41588-024-01966-6. https://pubmed.ncbi.nlm.nih.gov/39472694/
2. Dohnalkova, Michaela, Krasnykov, Kyrylo, Mendel, Mateusz, Homolka, David, Pillai, Ramesh S. 2023. Essential roles of RNA cap-proximal ribose methylation in mammalian embryonic development and fertility. In Cell reports, 42, 112786. doi:10.1016/j.celrep.2023.112786. https://pubmed.ncbi.nlm.nih.gov/37436893/
3. Avila-Bonilla, Rodolfo Gamaliel, Macias, Sara. 2024. The molecular language of RNA 5' ends: guardians of RNA identity and immunity. In RNA (New York, N.Y.), 30, 327-336. doi:10.1261/rna.079942.124. https://pubmed.ncbi.nlm.nih.gov/38325897/
4. Kim, Dae Won, Kim, Young-Chul, Kovari, Bence P, Imanirad, Iman, Kim, Richard D. 2024. Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer. In Cancers, 16, . doi:10.3390/cancers16030556. https://pubmed.ncbi.nlm.nih.gov/38339307/
5. Werner, Maria, Purta, Elzbieta, Kaminska, Katarzyna H, Jaworski, Jacek, Bujnicki, Janusz M. 2011. 2'-O-ribose methylation of cap2 in human: function and evolution in a horizontally mobile family. In Nucleic acids research, 39, 4756-68. doi:10.1093/nar/gkr038. https://pubmed.ncbi.nlm.nih.gov/21310715/
智鼠故事 
